These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 33348757

  • 1. Design, Synthesis and Comprehensive Investigations of Pyrrolo[3,4-d]pyridazinone-Based 1,3,4-Oxadiazole as New Class of Selective COX-2 Inhibitors.
    Szczukowski Ł, Krzyżak E, Zborowska A, Zając P, Potyrak K, Peregrym K, Wiatrak B, Marciniak A, Świątek P.
    Int J Mol Sci; 2020 Dec 17; 21(24):. PubMed ID: 33348757
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, biological evaluation and in silico studies of novel pyrrolo[3,4-d]pyridazinone derivatives withpromising anti-inflammatory and antioxidant activity.
    Szczukowski Ł, Redzicka A, Wiatrak B, Krzyżak E, Marciniak A, Gębczak K, Gębarowski T, Świątek P.
    Bioorg Chem; 2020 Sep 17; 102():104035. PubMed ID: 32721780
    [Abstract] [Full Text] [Related]

  • 3. In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone as Promising Cyclooxygenase Inhibitors.
    Peregrym K, Szczukowski Ł, Wiatrak B, Potyrak K, Czyżnikowska Ż, Świątek P.
    Int J Mol Sci; 2021 Aug 24; 22(17):. PubMed ID: 34502040
    [Abstract] [Full Text] [Related]

  • 4. New N-Substituted-1,2,4-triazole Derivatives of Pyrrolo[3,4-d]pyridazinone with Significant Anti-Inflammatory Activity-Design, Synthesis and Complementary In Vitro, Computational and Spectroscopic Studies.
    Szczukowski Ł, Krzyżak E, Wiatrak B, Jawień P, Marciniak A, Kotynia A, Świątek P.
    Int J Mol Sci; 2021 Oct 18; 22(20):. PubMed ID: 34681894
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, Biological, Spectroscopic and Computational Investigations of Novel N-Acylhydrazone Derivatives of Pyrrolo[3,4-d]pyridazinone as Dual COX/LOX Inhibitors.
    Mikus J, Świątek P, Przybyła P, Krzyżak E, Marciniak A, Kotynia A, Redzicka A, Wiatrak B, Jawień P, Gębarowski T, Szczukowski Ł.
    Molecules; 2023 Jul 18; 28(14):. PubMed ID: 37513351
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM, Kassab AE, El-Malah AA, Hassan MSA.
    Eur J Med Chem; 2019 Jun 01; 171():25-37. PubMed ID: 30904755
    [Abstract] [Full Text] [Related]

  • 7. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM, Hassan MSA, El-Malah AA, Kassab AE.
    Bioorg Chem; 2020 Jan 01; 95():103497. PubMed ID: 31838289
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.
    Kashid BB, Salunkhe PH, Dongare BB, More KR, Khedkar VM, Ghanwat AA.
    Bioorg Med Chem Lett; 2020 Jun 15; 30(12):127136. PubMed ID: 32280025
    [Abstract] [Full Text] [Related]

  • 9. COX-1/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases.
    Redzicka A, Szczukowski Ł, Kochel A, Wiatrak B, Gębczak K, Czyżnikowska Ż.
    Bioorg Med Chem; 2019 Sep 01; 27(17):3918-3928. PubMed ID: 31345747
    [Abstract] [Full Text] [Related]

  • 10. New 1,3,4-Oxadiazole Derivatives of Pyridothiazine-1,1-Dioxide with Anti-Inflammatory Activity.
    Glomb T, Wiatrak B, Gębczak K, Gębarowski T, Bodetko D, Czyżnikowska Ż, Świątek P.
    Int J Mol Sci; 2020 Nov 30; 21(23):. PubMed ID: 33266208
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA, Fadaly WAA, Kamel GM, Elshaier YAMM, El-Magd MA.
    Bioorg Chem; 2019 Feb 30; 82():86-99. PubMed ID: 30278282
    [Abstract] [Full Text] [Related]

  • 12. Design and Synthesis of Novel 1,3,4-Oxadiazole and 1,2,4-Triazole Derivatives as Cyclooxygenase-2 Inhibitors with Anti-inflammatory and Antioxidant activity in LPS-stimulated RAW264.7 Macrophages.
    Hamoud MMS, Osman NA, Rezq S, A A Abd El-Wahab H, E A Hassan A, Abdel-Fattah HA, Romero DG, Ghanim AM.
    Bioorg Chem; 2022 Jul 30; 124():105808. PubMed ID: 35447409
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
    Rathore A, Rahman MU, Siddiqui AA, Ali A, Shaharyar M.
    Arch Pharm (Weinheim); 2014 Dec 30; 347(12):923-35. PubMed ID: 25303727
    [Abstract] [Full Text] [Related]

  • 14. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA, Nour MS, Salem MA, Arafa RK.
    Eur J Med Chem; 2019 Dec 01; 183():111693. PubMed ID: 31539778
    [Abstract] [Full Text] [Related]

  • 15. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
    Farzaneh S, Zeinalzadeh E, Daraei B, Shahhosseini S, Zarghi A.
    Anticancer Agents Med Chem; 2018 Dec 01; 18(2):295-301. PubMed ID: 28971779
    [Abstract] [Full Text] [Related]

  • 16. Green synthesis of therapeutically active 1,3,4-oxadiazoles as antioxidants, selective COX-2 inhibitors and their in silico studies.
    Nesaragi AR, Kamble RR, Dixit S, Kodasi B, Hoolageri SR, Bayannavar PK, Dasappa JP, Vootla S, Joshi SD, Kumbar VM.
    Bioorg Med Chem Lett; 2021 Jul 01; 43():128112. PubMed ID: 33991632
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, COX-2 inhibition, anti-inflammatory activity, molecular docking, and histopathological studies of new pyridazine derivatives.
    Ewieda SY, Hassan RA, Ahmed EM, Abdou AM, Hassan MSA.
    Bioorg Chem; 2024 Sep 01; 150():107623. PubMed ID: 39002251
    [Abstract] [Full Text] [Related]

  • 18. Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity.
    Abouzid K, Bekhit SA.
    Bioorg Med Chem; 2008 May 15; 16(10):5547-56. PubMed ID: 18430576
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of Hybrids of Dihydropyrimidine and Pyridazinone as potential Anti-Breast Cancer Agents.
    Akhtar W, Verma G, Khan MF, Shaquiquzzaman M, Rana A, Anwer T, Akhter M, Alam MM.
    Mini Rev Med Chem; 2018 May 15; 18(4):369-379. PubMed ID: 28486908
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors.
    Kim KJ, Choi MJ, Shin JS, Kim M, Choi HE, Kang SM, Jin JH, Lee KT, Lee JY.
    Bioorg Med Chem Lett; 2014 Apr 15; 24(8):1958-62. PubMed ID: 24656662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.